Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021

Andrew D. Marques, Scott Sherrill-Mix, John Everett, Shantan Reddy, Pascha Hokama, Aoife M. Roche, Young Hwang, Abigail Glascock, Samantha A. Whiteside, Jevon Graham-Wooten, Layla A. Khatib, Ayannah S. Fitzgerald, Ahmed M. Moustafa, Colleen Bianco, Swetha Rajagopal, Jenna Helton, Regan Deming, Lidiya Denu, Azad Ahmed, Eimear Kitt, Susan E. Coffin, Claire Newbern, Josh Chang Mell, Paul J. Planet, Nitika Badjatia, Bonnie Richards, Zi-Xuan Wang, Carolyn C. Cannuscio, Katherine M. Strelau, Anne Jaskowiak-Barr, Leigh Cressman, Sean Loughrey, Arupa Ganguly, Michael D. Feldman, Ronald G. Collman, Kyle G. Rodino, Brendan J. Kelly, Frederic D. Bushman
doi: https://doi.org/10.1101/2021.10.18.21264623
Andrew D. Marques
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Sherrill-Mix
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Everett
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shantan Reddy
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascha Hokama
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aoife M. Roche
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Young Hwang
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abigail Glascock
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha A. Whiteside
2Pulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jevon Graham-Wooten
2Pulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Layla A. Khatib
2Pulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayannah S. Fitzgerald
2Pulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmed M. Moustafa
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
4Division of Gastroenterology, Hepatology & Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colleen Bianco
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swetha Rajagopal
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenna Helton
5Division of COVID-19 Containment, Philadelphia Department of Public Health, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regan Deming
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lidiya Denu
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azad Ahmed
6Department of Microbiology & Immunology, Center for Genomic Sciences, Drexel University College of Medicine. Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eimear Kitt
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
7Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Coffin
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
7Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Newbern
5Division of COVID-19 Containment, Philadelphia Department of Public Health, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josh Chang Mell
6Department of Microbiology & Immunology, Center for Genomic Sciences, Drexel University College of Medicine. Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Planet
3Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA
7Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
8Sackler Institute for Comparative Genomics, American Museum of Natural History, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nitika Badjatia
9Molecular & Genomic Pathology Laboratory, Thomas Jefferson University Hospital, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie Richards
10Jefferson Occupational Health Network for Employees and Students (JOHN), Thomas Jefferson University, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zi-Xuan Wang
9Molecular & Genomic Pathology Laboratory, Thomas Jefferson University Hospital, Philadelphia, PA
11Department of Anatomy, Pathology, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn C. Cannuscio
12Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
13Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine M. Strelau
12Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
13Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Jaskowiak-Barr
14Division of Infectious Diseases; Department of Medicine & Department of Biostatistics, Epidemiology, and Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leigh Cressman
14Division of Infectious Diseases; Department of Medicine & Department of Biostatistics, Epidemiology, and Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Loughrey
14Division of Infectious Diseases; Department of Medicine & Department of Biostatistics, Epidemiology, and Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arupa Ganguly
15Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Feldman
16Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald G. Collman
2Pulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyle G. Rodino
16Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bushman@pennmedicine.upenn.edu brendank@pennmedicine.upenn.edu Kyle.Rodino@Pennmedicine.upenn.edu
Brendan J. Kelly
14Division of Infectious Diseases; Department of Medicine & Department of Biostatistics, Epidemiology, and Informatics; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bushman@pennmedicine.upenn.edu brendank@pennmedicine.upenn.edu Kyle.Rodino@Pennmedicine.upenn.edu
Frederic D. Bushman
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bushman@pennmedicine.upenn.edu brendank@pennmedicine.upenn.edu Kyle.Rodino@Pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The severe acute respiratory coronavirus-2 (SARS-CoV-2) is the cause of the global outbreak of COVID-19. Evidence suggests that the virus is evolving to allow efficient spread through the human population, including vaccinated individuals. Here we report a study of viral variants from surveillance of the Delaware Valley, including the city of Philadelphia, and variants infecting vaccinated subjects. We sequenced and analyzed complete viral genomes from 2621 surveillance samples from March 2020 to September 2021 and compared them to genome sequences from 159 vaccine breakthroughs. In the early spring of 2020, all detected variants were of the B.1 and closely related lineages. A mixture of lineages followed, notably including B.1.243 followed by B.1.1.7 (alpha), with other lineages present at lower levels. Later isolations were dominated by B.1.617.2 (delta) and other delta lineages; delta was the exclusive variant present by the last time sampled. To investigate whether any variants appeared preferentially in vaccine breakthroughs, we devised a model based on Bayesian autoregressive moving average logistic multinomial regression to allow rigorous comparison. This revealed that B.1.617.2 (delta) showed three-fold enrichment in vaccine breakthrough cases (odds ratio of 3; 95% credible interval 0.89-11). Viral point substitutions could also be associated with vaccine breakthroughs, notably the N501Y substitution found in the alpha, beta and gamma variants (odds ratio 2.04; 95% credible interval of 1.25-3.18). This study thus provides a detailed picture of viral evolution in the Delaware Valley and a geographically matched analysis of vaccine breakthroughs; it also introduces a rigorous statistical approach to interrogating enrichment of viral variants.

Importance SARS-CoV-2 vaccination is highly effective at reducing viral infection, hospitalization and death. However, vaccine breakthrough infections have been widely observed, raising the question of whether particular viral variants or viral mutations are associated with breakthrough. Here we report analysis of 2621 surveillance isolates from xsxpeople diagnosed with COVID-19 in the Delaware Valley in South Eastern Pennsylvania, allowing rigorous comparison to 159 vaccine breakthrough case specimens. Our best estimate is a three-fold enrichment for some lineages of delta among breakthroughs, and enrichment of a notable spike substitution, N501Y. We introduce statistical methods that should be widely useful for evaluating vaccine breakthroughs and other viral phenotypes.

Competing Interest Statement

RG Collman reports support to his lab for COVID-19 work unrelated to the current manuscript from OraSure, Inc, and ongoing collaborations with Resilient Biotics, Inc. All other authors have no competing interests to report.

Funding Statement

Funding was provided by a contract award from the Centers for Disease Control and Prevention (CDC BAA 200-2021-10986 and 75D30121C11102/000HCVL1-2021-55232), philanthropic donations to the Penn Center for Research on Coronaviruses and Other Emerging Pathogens, and in part by NIH grant R61/33-HL137063 and AI140442 -supplement for SARS-CoV-2. BJK is supported by NIH K23 AI 121485. Additional assistance was provided by the Penn Center for AIDS Research (P30-AI045008) and the Women's Committee of CHOP.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The University of Pennsylvania Institutional Review Board (IRB) reviewed the research protocol and deemed the limited data elements extracted with positive SARS-CoV-2 specimens to be exempt from human subject research per 45 CFR 46.104, category 4 (IRB #848605). For hospitalized subjects at the University of Pennsylvania, following informed consent (IRB protocol #823392), patients were sampled by collection of saliva, oropharyngeal and/or nasopharyngeal swabs, or endotracheal aspirates if intubated, as previously described (33). Clinical data was extracted from the electronic medical record. Further samples were collected from asymptomatic subjects detected in a screening program at the Perelman School of Medicine at the University of Pennsylvania and symptomatic subjects tested throughout the PennMedicine clinical network under IRB protocols #843565 and #848608. Human samples were collected at Children’s Hospital of Philadelphia under protocol # 21-018726 approved by the Children's Hospital of Philadelphia IRB. Human samples were collected at Thomas Jefferson University under protocol number IRB Control # 21E.441 approved by the Thomas Jefferson University IRB.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* co-first authors

Data Availability

All viral genome sequences acquired in this study have been deposited in GISAID and at NCBI under accession numbers listed in Table S1. Analysis code is available at http://github.com/sherrillmix/longitudinalLineages and will be deposited on Zenodo prior to final submission. Sequence processing software and intermediate files used in this study are available at DOI:10.5281/zenodo.5559699. A list of key reagents used in this study is in Table S8.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted October 20, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Andrew D. Marques, Scott Sherrill-Mix, John Everett, Shantan Reddy, Pascha Hokama, Aoife M. Roche, Young Hwang, Abigail Glascock, Samantha A. Whiteside, Jevon Graham-Wooten, Layla A. Khatib, Ayannah S. Fitzgerald, Ahmed M. Moustafa, Colleen Bianco, Swetha Rajagopal, Jenna Helton, Regan Deming, Lidiya Denu, Azad Ahmed, Eimear Kitt, Susan E. Coffin, Claire Newbern, Josh Chang Mell, Paul J. Planet, Nitika Badjatia, Bonnie Richards, Zi-Xuan Wang, Carolyn C. Cannuscio, Katherine M. Strelau, Anne Jaskowiak-Barr, Leigh Cressman, Sean Loughrey, Arupa Ganguly, Michael D. Feldman, Ronald G. Collman, Kyle G. Rodino, Brendan J. Kelly, Frederic D. Bushman
medRxiv 2021.10.18.21264623; doi: https://doi.org/10.1101/2021.10.18.21264623
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Andrew D. Marques, Scott Sherrill-Mix, John Everett, Shantan Reddy, Pascha Hokama, Aoife M. Roche, Young Hwang, Abigail Glascock, Samantha A. Whiteside, Jevon Graham-Wooten, Layla A. Khatib, Ayannah S. Fitzgerald, Ahmed M. Moustafa, Colleen Bianco, Swetha Rajagopal, Jenna Helton, Regan Deming, Lidiya Denu, Azad Ahmed, Eimear Kitt, Susan E. Coffin, Claire Newbern, Josh Chang Mell, Paul J. Planet, Nitika Badjatia, Bonnie Richards, Zi-Xuan Wang, Carolyn C. Cannuscio, Katherine M. Strelau, Anne Jaskowiak-Barr, Leigh Cressman, Sean Loughrey, Arupa Ganguly, Michael D. Feldman, Ronald G. Collman, Kyle G. Rodino, Brendan J. Kelly, Frederic D. Bushman
medRxiv 2021.10.18.21264623; doi: https://doi.org/10.1101/2021.10.18.21264623

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)